| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Hyderabad Eye Research Foundation, L. V. Prasad Eye Institute, Hyderabad, India; and the 2 Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India.
PURPOSE. To determine the possible molecular genetic defect underlying primary congenital glaucoma (PCG) in India and to identify the pathogenic mutations causing this childhood blindness.
METHODS. Twenty-two members of five clinically well-characterized consanguineous families were studied. The primary candidate gene CYP1B1 was amplified from genomic DNA, sequenced, and analyzed in control subjects and patients to identify the disease-causing mutations.
RESULTS. Five distinct mutations were identified in the coding region of CYP1B1 in eight patients of five PCG-affected families, of which three mutations are novel. These include a novel homozygous frameshift, compound heterozygous missense, and other known mutations. One family showed pseudodominance, whereas others were autosomal recessive with full penetrance. In contrast to all known CYP1B1 mutations, the newly identified frameshift is of special significance, because all functional motifs are missing. This, therefore, represents a rare example of a natural functional CYP1B1 knockout, resulting in a null allele (both patients are blind).
CONCLUSIONS. The molecular mechanism leading to the development of PCG is unknown. Because CYP1B1 knockout mice did not show a glaucoma phenotype, the functional knockout identified in this study has important implications in elucidating the pathogenesis of PCG. Further understanding of how this molecular defect leads to PCG could influence the development of specific therapies. This is the first study to describe the molecular basis of PCG from the Indian subcontinent and has profound and multiple clinical implications in diagnosis, genetic counseling, genotype-phenotype correlations and prognosis. Hence, it is a step forward in preventing this devastating childhood blindness.
This article has been cited by other articles:
|
|
 |
|
  S. Chakrabarti, K. R. Devi, S. Komatireddy, K. Kaur, R. S. Parikh, A. K. Mandal, G. Chandrasekhar, and R. Thomas Glaucoma-Associated CYP1B1 Mutations Share Similar Haplotype Backgrounds in POAG and PACG Phenotypes Invest. Ophthalmol. Vis. Sci., December 1, 2007; 48(12): 5439 - 5444. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Chitsazian, B. K. Tusi, E. Elahi, H. A. Saroei, M. H. Sanati, S. Yazdani, M. Pakravan, N. Nilforooshan, Y. Eslami, M. A. Z. Mehrjerdi, et al. CYP1B1 Mutation Profile of Iranian Primary Congenital Glaucoma Patients and Associated Haplotypes J. Mol. Diagn., July 1, 2007; 9(3): 382 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Achary, A. B. M. Reddy, S. Chakrabarti, S. G. Panicker, A. K. Mandal, N. Ahmed, D. Balasubramanian, S. E. Hasnain, and H. A. Nagarajaram Disease-Causing Mutations in Proteins: Structural Analysis of the CYP1b1 Mutations Causing Primary Congenital Glaucoma in Humans Biophys. J., December 15, 2006; 91(12): 4329 - 4339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bidinost, N. Hernandez, D. P. Edward, A. Al-Rajhi, R. A. Lewis, J. R. Lupski, D. W. Stockton, and B. A. Bejjani Of mice and men: tyrosinase modification of congenital glaucoma in mice but not in humans. Invest. Ophthalmol. Vis. Sci., April 1, 2006; 47(4): 1486 - 1490. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Chakrabarti, K. Kaur, I. Kaur, A. K. Mandal, R. S. Parikh, R. Thomas, and P. P. Majumder Globally, CYP1B1 Mutations in Primary Congenital Glaucoma Are Strongly Structured by Geographic and Haplotype Backgrounds Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 43 - 47. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Melki, E Colomb, N Lefort, A P Brezin, and H-J Garchon CYP1B1 mutations in French patients with early-onset primary open-angle glaucoma J. Med. Genet., September 1, 2004; 41(9): 647 - 651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Panicker, A. K. Mandal, A. B. M. Reddy, V. K. Gothwal, and S. E. Hasnain Correlations of Genotype with Phenotype in Indian Patients with Primary Congenital Glaucoma Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1149 - 1156. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D F Sena, S Finzi, K Rodgers, E Del Bono, J L Haines, and J L Wiggs Founder mutations of CYP1B1 gene in patients with congenital glaucoma from the United States and Brazil J. Med. Genet., January 1, 2004; 41(1): e6 - 6. [Full Text] [PDF]
|
|
|
|
|
|
A. B. M. Reddy, S. G. Panicker, A. K. Mandal, S. E. Hasnain, and D. Balasubramanian Identification of R368H as a Predominant CYP1B1 Allele Causing Primary Congenital Glaucoma in Indian Patients Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4200 - 4203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y Ohtake, T Tanino, Y Suzuki, H Miyata, M Taomoto, N Azuma, H Tanihara, M Araie, and Y Mashima Phenotype of cytochrome P4501B1 gene (CYP1B1) mutations in Japanese patients with primary congenital glaucoma Br. J. Ophthalmol., March 1, 2003; 87(3): 302 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Borras, T. V. Morozova, S. L. Heinsohn, R. F. Lyman, T. F. C. Mackay, and R. R. H. Anholt Transcription Profiling in Drosophila Eyes That Overexpress the Human Glaucoma-Associated Trabecular Meshwork-Inducible Glucocorticoid Response Protein/Myocilin (TIGR/MYOC) Genetics, February 1, 2003; 163(2): 637 - 645. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
